[Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis].


OBJECTIVES To report adverse events registered in our population affected by JIA and treated with anti-TNFalpha blockers. METHODS Ninety-five patients were enrolled to be treated with Etanercept, median age 14 years (range 4-34); median duration of therapy 12 months (range 1-40). 19 patients were also treated with MTX (median dose 12.5 mg/week). Fifty-six… (More)


  • Presentations referencing similar topics